发明名称 |
FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME |
摘要 |
The invention is directed to a fusion protein comprising at least one FGF-21 (fibroblast growth factor-21) compound and at least one GLP-1R (glucagon-like peptide-1 receptor) agonist as well as to pharmaceutical compositions, medical uses and methods of treatment involving the fusion protein, particularly in the field of diabetes, dyslipidemia, obesity and/or adipositas. |
申请公布号 |
SG11201500682W(A) |
申请公布日期 |
2015.02.27 |
申请号 |
SG11201500682W |
申请日期 |
2013.09.04 |
申请人 |
SANOFI |
发明人 |
BOSCHEINEN, OLIVER;DREYER, MATTHIAS;HABERMANN, PAUL;SCHAEFER, HANS-LUDWIG;SOMMERFELD, MARK;LANGER, THOMAS |
分类号 |
C07K14/50;A61K38/18;A61K38/26;C07K14/605 |
主分类号 |
C07K14/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|